Close

MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy May 2, 2023 08:00AM
Today’s Important Price Target Changes Oct 13, 2022 05:40PM
Seagen (SGEN) Raised to Outperform at RBC, Analyst Rates Takeover Chances at 95% Aug 16, 2022 09:19AM
UPDATE: RBC Capital Upgrades Seagen (SGEN) to Outperform Aug 15, 2022 05:08PM
UPDATE: RBC Capital Downgrades Seagen (SGEN) to Sector Perform Feb 1, 2021 06:19AM


Sep 14, 2020 01:59PM Seattle Genetics (SGEN) PT Raised to $191 at RBC Capital
Oct 22, 2019 07:28AM Seattle Genetics (SGEN) PT Raised to $109 at RBC Capital
Oct 21, 2019 09:21AM Pre-Open 10/21: (MDR) (OPK) (FSCT) Higher (KMT) (IPHS) (BA) Lower (more...)
Jul 26, 2019 11:49AM Seattle Genetics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
Jul 24, 2019 05:52AM Seattle Genetics (SGEN) Prices 7.14M Share Offering at $70/Sh
Jul 23, 2019 10:26PM Seattle Genetics Announces Pricing of Public Offering of Common Stock
Jul 17, 2019 06:47AM Seattle Genetics (SGEN) PT Raised to $80 at RBC Capital
May 15, 2019 08:00AM Seattle Genetics to Present at RBC Capital Markets 2019 Global Healthcare Conference
Apr 26, 2019 07:08AM Seattle Genetics (SGEN) PT Lowered to $79 at RBC Capital
Apr 5, 2019 06:42AM Seattle Genetics (SGEN) PT Raised to $90 at RBC Capital; KEYNOTE-204 Delay Removes Overhang
Mar 29, 2019 06:44AM Seattle Genetics (SGEN) PT Raised to $89 at RBC Capital
Mar 12, 2019 06:35AM RBC Capital Reiterates Outperform Rating on Seattle Genetics (SGEN); KN-204 Data a 'Non-Event'
Oct 26, 2018 07:35AM Seattle Genetics (SGEN) PT Lowered to $92 at RBC Capital
Oct 1, 2018 11:14AM Seattle Genetics (SGEN) PT Raised to $98 at RBC Capital
Mar 21, 2018 07:54AM Seattle Genetics (SGEN) PT Raised to $73 at RBC Capital
Jan 31, 2018 09:24AM Pre-Open Movers 01/31: (CASC) (SFLY) (KNX) Higher; (BLCM) (MGI) (CACC) Lower (more...)
Sep 14, 2017 04:29PM RBC Capital Starts Seattle Genetics (SGEN) at Outperform
Aug 21, 2016 06:12PM Pfizer boosts cancer drug roster with $14 billion Medivation deal
Sep 14, 2015 08:00AM Seattle Genetics Announces Exercise of Over-Allotment Option
Sep 11, 2015 07:18AM Seattle Genetics (SGEN) Prices 11.7M Common Stock Offering at $41/Share
Sep 10, 2015 06:19PM Seattle Genetics Announces Pricing of Public Offering of Common Stock
Feb 12, 2014 09:35AM Pre-Open Stock Movers 2/12: (OC) (CSTE) (TRIP) Higher; (VTUS) (RLOC) (PRGN) Lower (more...)
Nov 11, 2011 11:26AM Notable Analyst Rating Changes 11/11: (LSCC) (GNW) (DNDN) Upgraded; (CAG) (BRLI) (FSLR) Downgraded
Feb 1, 2011 04:40PM Seattle Genetics (SGEN) To Offer Common Shares
Nov 9, 2010 10:50AM Notable Analyst Rating Changes 11/09: DNN, CCJ, SYMC, GHDX Upgraded; AKS, RIMM, CXW, UEC Downgraded
Aug 31, 2010 10:20AM Notable Analyst Rating Changes 08/31: GPS, ANF, BMY, UBS Upgraded; HPQ, DGIT, RAX, POT Downgraded
Mar 19, 2008 07:01AM RBC Capital Upgrades Seattle Genetics (SGEN) To Outperform